Roles of transcriptional factor Snail and adhesion factor E-cadherin in clear cell renal cell carcinoma

Similar documents
Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma

Correlation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer

Clinical significance of CD44 expression in children with hepatoblastoma

Study on the expression of MMP-9 and NF-κB proteins in epithelial ovarian cancer tissue and their clinical value

Tumor microenvironment Interactions and Lung Cancer Invasiveness. Pulmonary Grand Rounds Philippe Montgrain, M.D.

Clinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma

The expression and significance of tumor associated macrophages and CXCR4 in non-small cell lung cancer

Expression and clinical significance of ADAM17 protein in esophageal squamous cell carcinoma

Original Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical outcome

Detection and Clinical Significance of Lymph Node Micrometastasis in Gastric Cardia Adenocarcinoma

Association of BTBD7 with Metastasis and Poor Prognosis in Non-Small-Cell Lung Cancer Patients

Patterns of E.cadherin and Estrogen receptor Expression in Histological Sections of Sudanese Patients with Breast Carcinoma

Cancer Biology Course. Invasion and Metastasis

Original Article Clinical significance of SOX2 and snail expression in esophageal squamous cell carcinoma

In vitro scratch assay: method for analysis of cell migration in vitro labeled fluorodeoxyglucose (FDG)

Fundamental research on breast cancer in Belgium. Rosita Winkler

Research Article Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67

Cell Polarity and Cancer

RCD24, B7-H4 and PCNA expression and clinical significance in ovarian cancer

Expressions of PS-2, CA153 and VEGF and clinical significance in patients with breast cancer.

Original Article Expression of E-cadherin and vimentin in oral squamous cell carcinoma

Kidney Case 1 SURGICAL PATHOLOGY REPORT

Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar

Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar

ONCOLOGY LETTERS 5: , 2013

Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients

High expression of fibroblast activation protein is an adverse prognosticator in gastric cancer.

Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues

number Done by Corrected by Doctor Maha Shomaf

Function and clinical significance of SUMOylation in type I endometrial carcinoma

The Hallmarks of Cancer

Astrocyte Elevated Gene 1 (AEG-1): A Promising Candidate for Molecular Targeted Therapy in Oral Squamous Cell Carcinomas

Expression and significance of SATB1 in the development of breast cancer

DOCTORAL THESIS SUMMARY

Award Number: W81XWH TITLE: Characterizing an EMT Signature in Breast Cancer. PRINCIPAL INVESTIGATOR: Melanie C.

6/5/2010. Renal vein invasion & Capsule Penetration (T3a) Adrenal Gland involvement (T4 vs. M1) Beyond Gerota s Fascia? (?T4).

Case Report Five-Year Survival after Surgery for Invasive Micropapillary Carcinoma of the Stomach

Significance and prognosis of epithelial cadherin expression in invasive breast carcinoma

Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma

Expression and Significance of GRP78 and HER-2 in Colorectal Cancer

Paget's Disease of the Breast: Clinical Analysis of 45 Patients

P atients with primary breast cancer have an increased risk of developing contralateral breast cancer1. When

Role of cyclin E and p53 expression in progression of early gastric cancer

Expression of Thyroid Transcription Factor-1 (TTF-1) in Lung Carcinomas and Its Correlations with Apoptosis and Angiogenesis

CHAPTER VII CONCLUDING REMARKS AND FUTURE DIRECTION. Androgen deprivation therapy is the most used treatment of de novo or recurrent

Expression of long non-coding RNA linc-itgb1 in breast cancer and its influence on prognosis and survival

(A) RT-PCR for components of the Shh/Gli pathway in normal fetus cell (MRC-5) and a

Neoplasia 18 lecture 8. Dr Heyam Awad MD, FRCPath

WHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER?

Supplementary Figure 1. HOPX is hypermethylated in NPC. (a) Methylation levels of HOPX in Normal (n = 24) and NPC (n = 24) tissues from the

Expression of E-cadherin and b-catenin is Altered at Tumor Budding Sites, Whose Number is Associated with the Progression of Colorectal Carcinoma

Claudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression

Low levels of serum mir-99a is a predictor of poor prognosis in breast cancer

Original Article Expression of FOXC2 in renal cell carcinoma and its relationship to clinical pathological features

Type of file: PDF Size of file: 0 KB Title of file for HTML: Supplementary Information Description: Supplementary Figures

Does EMT Contribute to Radiation Resistance in Human Breast Cancer?

Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, P. R. China; 2

1. The metastatic cascade. 3. Pathologic features of metastasis. 4. Therapeutic ramifications. Which malignant cells will metastasize?

E-Cadherin Expression as a Prognostic Factor in Transitional Cell Carcinoma of the Bladder After Transurethral Resection

Roles of the AIB1 protein in the proliferation and transformation of human esophageal squamous cell carcinoma

Contents 1 The Windows of Susceptibility to Breast Cancer 2 The So Called Pre-Neoplastic Lesions and Carcinoma In Situ

Differentiation of Tumors with Specific Red Cell Adherence (SRCA) test

Cancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC

Study of expression of P53 in Gastric Carcinoma As a prognostic indicator

P16 GENE EXPRESSION IN OVARIAN EPITHELIAL CYSTADENOCARCINOMA

TitleSarcomatoid carcinoma of the bladde.

RESEARCH ARTICLE. Wen-Shuang Wang 1,2, Xing-Sheng Yang 2, Min Xia 1, Hai-Yang Jiang 1, Jian-Qing Hou 1 * Abstract. Introduction

IMMUNOHISTOCHEMICAL EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) IN INVASIVE BREAST CARCINOMA

Soluble N-cadherin as a Biomarker for Malignant Bone and Soft Tissue Tumors

ACCME/Disclosures. Case History 4/13/2016. USCAP GU Specialty Conference Case 3. Ann Arbor, MI

Jung Hee Lee 1 Won Young Park 1 Seong Muk Jeong 1 Min Ki Lee 2,3 Young Dae Kim 3,4 Dong Hoon Shin 1,3 Chang Hun Lee 1,3

Immunohistochemical Expression Of Cytokeratin 8 And 18 In Breast Carcinoma.

Neoplasia part I. Dr. Mohsen Dashti. Clinical Medicine & Pathology nd Lecture

Molecular Characterization of Breast Cancer: The Clinical Significance

1.The metastatic cascade. 2.Pathologic features of metastasis. 3.Therapeutic ramifications

Triple Negative Breast Cancer

Original Article Prognostic role of neuroendocrine cell differentiation in human gastric carcinoma

Invasive Papillary Breast Carcinoma

Expression and clinical significance of Kelch-like epichlorohydrin-associated protein 1 in breast cancer

CD15 and CEA expression in thymic epithelial neoplasms

Positive nin one binding protein expression predicts poor outcome in prostate cancer

Case Report Aggressive invasive micropapillary salivary duct carcinoma of the parotid gland

Inhibition of Invasion and Metastasis of Gastric Cancer Cells Through Snail Targeting Artificial MicroRNA Interference

supplementary information

Abnormality of p16/p38mapk/p53/wipl pathway in papillary thyroid cancer

Definition of Synoptic Reporting

Attending Physician Statement- Cancer or Carcinoma in-situ

Biochemistry of Carcinogenesis. Lecture # 35 Alexander N. Koval

Androgen Receptor Expression in Renal Cell Carcinoma: A New Actionable Target?

mir-218 tissue expression level is associated with aggressive progression of gastric cancer

Gastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR

Evaluation of E-cadherin Expression in Gastric Cancer and Its Correlation with Clinicopathologic Parameters

Evaluation of HER2/neu oncoprotein in serum and tissue samples of women with breast cancer: Correlation with clinicopathological parameters

Comparative Study of Expression of Smad3 in Oral Lichen Planus and Normal Oral Mucosa

Xiang Hu*, Liang Cao*, Yi Yu. Introduction

A study on clinicopathological features and prognostic factors of patients with upper gastric cancer and middle and lower gastric cancer.

Gastric Cancer Histopathology Reporting Proforma

Basement membrane in lobule.

Dr. dr. Primariadewi R, SpPA(K)

Solitary Fibrous Tumor of the Kidney with Massive Retroperitoneal Recurrence. A Case Presentation

Transcription:

EXPERIMENTAL AND THERAPEUTIC MEDICINE 6: 1489-1493, 2013 Roles of transcriptional factor Snail and adhesion factor E-cadherin in clear cell renal cell carcinoma JINQUAN CAI Department of Urology, Fuzhou General Hospital of Nanjing Military Command of Chinese PLA, Fuzhou, Fujian 350025, P.R. China Received May 17, 2013; Accepted September 5, 2013 DOI: 10.3892/etm.2013.1345 Abstract. The aim of this study was to investigate the roles of the transcription factor Snail and adhesion factor epithelial-cadherin (E-cadherin) in clear cell renal cell carcinoma (CCRCC) and evaluate their correlation with tumor pathological grading, clinical stage, invasion and metastases. The expression of Snail and E-cadherin protein in 69 samples of CCRCC tissue, 58 samples of para-cancerous mucosa and 10 samples of normal renal tissue were detected using the immunohistochemical streptavidin- peroxidase method. The positivity rate of Snail in CCRCC was 82.61%, which was significantly higher than that in para-cancerous mucosa (43.10%, P<0.001). The positivity rate of E-cadherin in CCRCC was 31.88%, which was significantly lower than that in para-cancerous mucosa (91.38%, P<0.001). The expression of E-cadherin and Snail correlated significantly with tumor differential degree, clinical stage and the depth of tumor invasion and distant metastasis (P<0.05). There was a negative correlation between the expression of E-cadherin and Snail in CCRCC. The overexpression of Snail and reduced expression of E-cadherin may be important biological markers for the invasion and metastasis of CCRCC. The combined detection of E-cadherin and Snail has far-reaching significance for the prediction of CCRCC invasion and metastasis. Introduction Tumorigenesis, invasion and metastasis are complex processes involving several signaling pathways, cell factors and other tumor causing factors, and are among the main causes of mortality. Tumor invasion and metastasis, in addition to the biological activity of kidney cell transformation and migration, currently receive considerable attention. Metastatic Correspondence to: Professor Jinquan Cai, Department of Urology, Fuzhou General Hospital of Nanjing Military Command of Chinese PLA, No. 156 Xi E Huan Road, Fuzhou, Fujian 350025, P.R. China E-mail: jqcaicn@126.com Key words: clear cell renal cell carcinoma, E-cadherin, Snail, epithelial-mesenchymal transition kidney cancer is common in patients, and the treatment of renal cell carcinoma is becoming increasingly difficult. Thus, kidney cancer metastasis and infiltration are focal points in kidney cancer research. Biological treatments for kidney cancer have limited availability. In vitro studies on the side effects of gene therapy are limited, and the effects of specific clinical treatments remain unclear. Epithelial cadherin (E-cadherin), which is present in epithelial cells, mediates the connections between calcium-dependent adhesion molecules. E-cadherin, which is considered to be the most important type of calcium mucin and has been extensively studied, has the following characteristics: 533 amino acid residues at the N-terminal extracellular domain; 24 amino acid residues composed of highly hydrophobic molecules in the transmembrane domain; and 150 amino acid residues at the C-terminal intracellular domain (1). E-cadherin is vital for maintaining cell morphology (2), cell polarity and the connections between cells (3). Furthermore, E-cadherin is an important signal transduction molecule that participates in the transfer of information between cells (3). Snail is a zinc finger transcription factor. The structure of Snail consists of a variable N-terminal domain and 4-6 zinc fingers with a highly conserved C-terminal region (4). The mechanism of action for Snail involves the interaction of one of its zinc finger areas and the E-cadherin promoter region, E-box sequence (CAGGTG), on the main chain (5). Thus, Snail becomes a transcription inhibiting protein and serves as a repressor of E-cadherin (5). Previous studies have demonstrated that the mesenchymalepithelial transition in tumor infiltration during migration is closely associated with the development of epithelia-mesenchymal transition (EMT), and carcinoma cells already exist in EMT (6,7). Vincent-Salomon and Thiery (8) observed that breast cancer occurs as a result of infiltration, in which the EMT and migration play important roles. Similar observations have been made in colon (9) and liver cancers (10). The indispensable transformation of epithelial cells into mesenchymal cells results in their acquisition of interstitial cell characteristics. Hence, the cells become invasive. It has been confirmed that, in tumorigenesis, EMT affects numerous transduction factors, including Snail, which represses E-cadherin expression (11); this is considered to be a key link in tumorigenesis. Snail expression is observed in tumors showing features of EMT which causes the downregulation of the E-cadherin.

1490 CAI et al: ROLES OF SNAIL AND E-CADHERIN IN CLEAR CELL RENAL CELL CARCINOMA Snail expression and E-cadherin repression in clear cell renal cell carcinoma (CCRCC) are rarely studied. The present study used the immunohistochemical streptavidin-peroxidase (SP) method for the combined detection of Snail and E-cadherin in CCRCC, in the normal tissues adjacent to the tumor and in normal tissues. The expression characteristics in the CCRCC were analyzed using clinical and pathological factors. Correlation between these factors would increase our understanding of the CCRCC infiltration and migration mechanism and may provide a new theoretical basis for future targeted therapy for the prevention and treatment of CCRCC infiltration and migration. Materials and methods General data. Patients aged 27-79 years (mean age: 58.41 years) were recruited from the Fuzhou General Hospital of Nanjing Military Command of Chinese PLA (Fuzhou, China) from October 2010 to June 2011. Patients were classified according to the American Joint Committee on Cancer (AJCC; 2002) TNM staging system, and the conditions were staged and graded using the Fuhrman grading system: G1, G2, G3, G4, representing high differentiation, differentiation, low differentiation, undifferentiated, respectively.. Tissue samples from 69 patients with CCRCC who had undergone radical nephrectomy were obtained preoperatively prior to the administration of any related cancer treatment. Postoperative diagnosis was performed following the pathological examination of CCRCC. Subsequently, 58 samples from normal tissues adjacent to the tumor and 10 samples from normal renal tissue were obtained and compared. This study was conducted in accordance with the Declaration of Helsinki and with approval from the Ethics Committee of Fuzhou General Hospital of Nanjing Military Command of Chinese PLA. Written informed consent was obtained from all participants. Immunohistochemical study. All specimens (4-µm-thick sections) were fixed with 10% formalin and embedded in paraffin, followed by preparation of 4 µm sections. 0.01 mol/l citrate buffer was added for antigen repair. The sections were examined using the SP immunohistochemical staining method. The procedure with 3,3'-diaminobenzidine staining, hematoxylin counterstaining and transparent sealing was performed according to the manufacturer's instructions. Rabbit anti-human E-cadherin polyclonal antibody (1:100 dilution) and Rabbit anti-human Snail antibody (1:150 dilution) were provided by Beijing Biosynthesis Biotechnology Co., Ltd. (Beijing, China). Immunohistochemical SP kit was provided by Zymed Laboratories Inc. (San Francisco, CA, USA). Phosphate-buffered saline instead of primary antibody was used as negative control. Judgment standard. Experimental specimens were randomly observed under a high-power field microscope (magnification, x400), and the proportion of positive cells (positivity rate) was calculated based on the positive expression (demonstrated by yellow staining) of E-cadherin and Snail in the CCRCC. The samples were determined to be positive or negative according to positive cell number: positive cell number 25%, positive; no positive staining or positive cell number <25%, negative (12). Figure 1. Positive expression of E-cadherin in normal renal tissues (magnification, Figure 2. Positive expression of E-cadherin in para-cancerous mucosa (magnification, Figure 3. Negative expression of E-cadherin in clear cell renal cell carcinoma (magnification, Statistical analysis. SPSS 17.0 statistical software (SPSS, Inc., Chicago, IL, USA) was used to perform the statistical analysis. The rates and relationships between two groups of variables were compared and evaluated using the χ 2 -test and Spearman rank correlation analysis, respectively. P<0.05 was considered to indicate a statistically significant result. Results Comparison of E-cadherin and Snail expression. E-cadherin expression was observed as yellow particles in the cytoplasm or membrane of normal renal cells. A low level of E-cadherin expression was detected in CCRCC. The para-cancerous and normal tissue exhibits a higher expression rate, which is located mainly in the cytoplasm and/or membranes (Figs. 1-3). The positivity rates in the tumor, normal tissues

EXPERIMENTAL AND THERAPEUTIC MEDICINE 6: 1489-1493, 2013 1491 Figure 4. Negative expression of Snail in normal renal tissues (magnification, Table I. E-cadherin and Snail expression in various tissues. E-cadherin Snail ---------------------------- ---------------------------- Tissue type n + Rate (%) + Rate (%) Carcinoma 69 22 31.88 57 82.61 Tumor-adjacent 58 53 91.38 25 43.10 Normal 10 10 100.00 1 10.00 +, Positive; CCRCC, clear cell renal cell carcinoma. Correlation of E-cadherin and Snail expression in CCRCC. Spearman rank correlation analysis revealed that the positive expression of E-cadherin is repressed as the positive expression of Snail increases; the expression of E cadherin and Snail in the CCRCC is negatively correlated (r=0.342, P=0.004; Table III). Discussion Figure 5. Weak positive expression of Snail in para-cancerous mucosa (magnification, Figure 6. Positive expression of Snail in clear cell renal cell carcinoma (magnification, adjacent to the tumor and normal tissues were 31.88, 91.38, and 100.00%, respectively, with a statistically significant difference (P<0.001). Snail is highly expressed in CCRCC (Figs. 4-6), with positivity rates of 82.61, 43.10 and 10.00% in the tumor, normal tissues adjacent to the tumor and normal tissues, respectively. The differences in the expression rates were statistically significant (P<0.001; Table I). E-cadherin and Snail expression at various clinical stages. In CCRCC, the expression of E-cadherin and Snail was correlated with clinical stage and histological grade, in addition to distant and lymph node metastases (contingency coefficient r-values are shown in Table II; P<0.05). The age and gender of the patients demonstrated no significant correlation (contingency coefficient r values are listed in Table II; P>0.05). Numerous studies have shown that EMT plays an important role in the development of malignant epithelial tumors (6). A previous study has shown that during tumorigenesis and migration in the early stage of cancer, EMT results in the formation of cancer cells with specific connective tissue damage and diffused tumor cell invasion into the surrounding tissue and blood vessels (13). The EMT is also involved in embryonic neural embryo and gastrula formation and is one of the most important cell mechanisms during organ development. A number of studies have demonstrated that EMT also plays an important role in tumor development in the bladder (14), stomach (15), and colon (9), in addition to the development of malignant epithelial tumors. The mechanisms of EMT are as follows: i) Cell polarity is lost such that the expression of molecules related to cell adhesion is repressed, resulting in the destruction of the connection between specific cells. ii) The cell morphology is altered such that similar interstitial cell characteristics are obtained, accompanied by a series of changes to the molecular composition, making the cell vulnerable to strong attacks (7). In the current study, we used a high-power microscope in order to view the cancer cells and observed that the arrangement of the cancer cells was looser compared with that of the normal renal tissue cells such that the connections between the cancer cells were not closed; the normal, organized kidney structure was lost. These observations supported the possible presence of a mechanism that leads to the formation of tumor cell connections between transformations, resulting in easy diffusion and migration. This mechanism is likely to be the EMT. Neve et al (16) and Charafe-Jauffret et al (17) applied the Affymetrix gene chip and proteomic principles to analyze a variety of breast cancer cell lines and observed high expression of interstitial molecular markers in the highly aggressive cell line, contrary to the low-invasive and well-differentiated cells in which the interstitial molecular markers have low expression levels or may be missing. EMT may close the connection between cells during tumor development.

1492 CAI et al: ROLES OF SNAIL AND E-CADHERIN IN CLEAR CELL RENAL CELL CARCINOMA Table II. E-cadherin and Snail CCRCC in different stages and classifications and the relationship between clinical parameters E-cadherin Snail -------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------ Clinical parameters n + Rate (%) χ 2 P-value r + Rate (%) χ 2 P-value r Classification 7.921 0.048 0.321 13.020 0.005 0.398 G1 11 7 63.63 5 45.45 G2 33 10 30.30 29 87.88 G3 20 5 25.00 18 90.00 G4 5 0 0.00 5 100.00 TNM 8.810 0.032 0.336 9.217 0.027 0.343 T1 36 17 47.22 25 69.44 T2 20 4 20.00 19 95.00 T3 10 1 10.00 10 100.00 T4 3 0 0.00 3 100.00 Age (years) 0.051 0.821 0.027 0.608 0.435 0.093 <58 39 12 30.77 31 79.49 58 30 10 33.33 26 86.67 Gender 0.725 0.394 0.102 0.039 0.843 0.024 Male 42 15 35.71 35 83.33 Female 27 7 25.92 22 81.48 Lymphaden 7.773 0.005 0.318 5.127 0.024 0.263 ( ) 51 21 41.18 39 76.47 (+) 18 1 5.56 18 100.00 Metastases 8.972 0.003 0.328 4.035 0.045 0.235 M0 54 22 40.74 42 77.78 M1 15 0 0.00 15 100.00 +, positive; CCRCC, clear cell renal cell carcinoma. Table III. Relationship between E-cadherin and Snail in CCRCC. E-cadherin expression ------------------------------------------------ Snail expression Positive Negative Total Positive 14 43 57 Negative 8 4 12 r=-0.342, P=0.004. CCRCC, clear cell renal cell carcinoma. Snail is a type of zinc finger transcription factor, and its key targets in the occurrence of EMT have been identified. Snail acts through its zinc finger area and the E-cadherin promoter E-box region (sequence CAGGTG), on the main chain, thereby repressing E-cadherin expression. The downregulation of E-cadherin directly results in alterations to the cell morphology, loss of polarity, structural instability of the organisation and the destruction of the connections between epithelial cells, resulting in the tumor cells breaking away from the original site of tumor invasion and metastasis (4). Blanco et al (18) found that Snail expression reduced or completely inhibited E-cadherin expression in breast ductal carcinoma and various other tumors. E-cadherin, widely distributed in epithelial cells, is stably expressed in normal epithelial cells, but its expression is repressed or completely inhibited in gastric, liver and prostate cancers in addition to various other epithelial malignant tumors (19). This is consistent with the findings in the present study in which E-cadherin expression in CCRCC was observed to be downregulated. Furthermore, we studied Snail expression in CCRCC, para cancerous and normal tissues. A high level of Snail expression was observed in the cancerous tissue and in the majority of the histological grades, all cases of lymph node metastasis and stages. The detection of Snail and E-cadherin expression in normal tissue, normal tissues adjacent to tumor tissue and in CCRCC using the immunohistochemical method, in addition to the internal connection of these two factors, is rarely reported. The results from the present study demonstrate a high level of Snail expression in CCRCC with a positive expression rate of 82.61% compared with those in the normal tissues near the tumor and normal tissues. The tumor stage, classification, infiltration and metastasis are correlated with the expression of Snail. Hence, Snail, to a certain extent, may reflect the ability of the tumor cells to invade. We also observed that the positive expression of Snail in CCRCC significantly repressed E-cadherin expression (P<0.05). In CCRCC, the acceleration

EXPERIMENTAL AND THERAPEUTIC MEDICINE 6: 1489-1493, 2013 1493 of tumor invasion and metastasis by Snail may be achieved through the inhibition of E-cadherin expression. In conclusion, this study evaluated the EMT and the correlation between Snail and E-cadherin protein expression in CCRCC using an immunohistochemical method. The presence of Snail and E-cadherin expression in CCRCC correlates with the CCRCC staging and grading as well as with the lymph node and distant metastasis. Therefore, the joint detection of Snail and E-cadherin expression in CCRCC may be used as a biological marker to monitor CCRCC infiltration and migration. The effect of EMT may be the inhibition of tumor infiltration or metastasis. However, the role of transformation in tumor infiltration requires further study as the linking mechanism remains unclear. Further studies are required to confirm the results of this study for the comprehensive treatment of kidney tumors and provide a theoretical basis for tumor pathogenesis in the kidney. References 1. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-1455, 1991. 2. McNeill H, Ozawa M, Kemler R and Nelson WJ: Novel function of the cell adhesion molecule uvomorulin as an inducer of cell surface polarity. Cell 62: 309-316, 1990. 3. Andersen H, Mejlvang J, Mahmood S, et al: Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells. Mol Cell Biol 25: 9138-9150, 2005. 4. Rosivatz E, Becker I, Specht K, et al: Differential expression of the epithelial-mesenchymal transition regulators Snail, SIP1, and twist in gastric cancer. Am J Surg Pathol 161: 1881-1891, 2002. 5. Nieto MA: Epithelial-mesenchymal transitions in development and disease: old views and new perspectives. Int J Dev Biol 53: 1541-1547, 2009. 6. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2002. 7. Boyer B, Vallés AM and Edme N: Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol 60: 1091-1099, 2000. 8. Vincent-Salomon A and Thiery JP: Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res 5: 101-106, 2003. 9. Bates RC, DeLeo MJ 3rd and Mercurio AM: The epithelialmesenchymal transition of colon carcinoma involves expression of IL-8 and CXCR-1-mediated chemotaxis. Exp Cell Res 299: 315-234, 2004. 10. van Zijl F, Zulehner G, Petz M, et al: Epithelial-mesenchymal transition in hepatocellular carcinoma. Future Oncol 5: 1169-1179, 2009. 11. Wang L, Li Z, Wang C, et al: E-cadherin decreased human breast cancer cells sensitivity to staurosporine by up-regulating Bcl-2 expression. Arch Biochem Biophys 481: 116-122, 2009. 12. Gabbert HE, Mueller W, Schneiders A, Meier S, Moll R, Birchmeier W and Hommel G: Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer 69: 184-189, 1996. 13. De Wever O, Pauwels P, De Craene B, et al: Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem Cell Biol 130: 481-494, 2008. 14. Hou JQ, Wei JX, Chang JK and Li TQ: E - calcium sticky grain and actin crosslinked protein in bladder transitional cell carcinoma of the expression and its significance. Surg 28: 847-848, 2011 (In Chinese). 15. Castro Alves C, Rosivatz E, Schott C, et al: Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin. J Pathol 211: 507-515, 2007. 16. Neve RM, Chin K, Fridlyand J, et al: A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10: 515-527, 2006. 17. Charafe-Jauffret E, Ginestier C, Monville F, et al: Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 25: 2273-2284, 2006. 18. Blanco MJ, Moreno-Bueno G, Sarrio D, et al: Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 21: 3241-3246, 2002. 19. Peña C, Garcia JM, Silva J, et al: E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum Mol Genet 14: 3361-3370, 2005.